// App-Quantinova.ai

740 : Select Soluble Inflammatory Mediators Are Detected Prior to and Increase At Systemic Lupus Erythematosus Classification

Researchers

Presenter

  • Melissa E. Munroe

Principal Investigators

  • Jourdan R. Anderson

  • Julie M. Robertson

  • Timothy B. Niewold

  • George C. Tsokos

  • Michael P. Keith

  • John B. Harley

  • Judith A. James

Medical Centers

  • US Department of Veterans Affairs Medical Center, Cincinnati, OH

  • Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City,, OK

  • Medicine/Rheumatology, BIDMC, Harvard Medical School, Boston, MA

  • Oklahoma University Health Sciences Center, Oklahoma City, OK

  • Section of Rheumatology and Gwen Knapp Center for Lupus and Immunology Research, University of Chicago, Chicago, IL

  • Walter Reed National Military Medical Center, Gaithersburg, MD

  • Arthritis & Clinical immunology, OK Med Research Foundation, Oklahoma City, OK

  • Arthritis & Clinical immunology, OK Med Research Foundation, Oklahoma City, OK

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

Biomarkers

  • High sensitivity C-reactive protein

  • von Willebrand factor

  • Interferon

  • Albumin/creatinine

Drug/Treatment

  • Interferon

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved